Tilray's (NASDAQ:TLRY) Earnings Need a Scratch Below the Surface

Tilray, Inc.'s (NASDAQ: TLRY)story of 2021 has been the one of boom and bust (once again), as the stock repeated the performance from 2018 – albeit on a much smaller scale.

Although the stock gained on earnings results, digging deeper shows things are not what they seem.

Check out our latest analysis for Tilray

Advertisement

Second-quarter 2022 results:

  • EPS: US$0.013 (up from US$0.32 loss in 2Q 2021).
  • Revenue: US$155.2m (up 26% from 2Q 2021).
  • Net income: US$5.80m (up to US$98.6m from 2Q 2021).
  • Profit margin: 3.7% (up from a net loss in 2Q 2021).

Revenue missed analyst estimates by 9.3%, while earnings per share (EPS) exceeded analyst estimates. Over the next year, revenue is forecast to grow 19%, compared to a 16% growth forecast for the industry in the US.

earnings-and-revenue-history
NasdaqGS: TLRY Earnings and Revenue History January 12th, 2022

Yet, looking deeper, the critics have highlighted the following:

  • Actual EBIDTA was negative without adjustments that removed about US$29M
  • Operating loss rose significantly Y/Y
  • Sales decreased over 10% Q/Q for cannabis and beverage sales

Furthermore, according to our data, CEO's compensation vastly exceeds the average for companies of similar size.

NASDAQ: TLRY CEO Compensation Analysis January 12th, 2022

For 2021, the CEO's cash bonuses exceeded US$13m, with total compensation of nearly US$30m. This is around 20% of the quarterly revenues!

To understand the value of a company's earnings growth, it is imperative to consider any dilution of shareholders' interests. Tilray expanded the number of shares on issue by 47% over the last year. That means its earnings are split among a greater number of shares.

To celebrate net income while ignoring dilution is like rejoicing because you have a single slice of a larger pizza, but ignoring the fact that the pizza is now cut into many more slices. You can see a chart of Tilray's EPS by clicking here.

A Look At The Impact Of Tilray's Dilution on Its Earnings Per Share (EPS).

Unfortunately, we don't have any visibility into its profits three years back, because we lack the data. And in focusing only on the last twelve months, we don't have a meaningful growth rate because it made a loss a year ago, too. One can observe that the dilution has a fairly profound effect on shareholder returns.

If Tilray's EPS can grow over time, that drastically improves the chances of the share price moving in the same direction. But on the other hand, we'd be far less excited to learn profit (but not EPS) was improving. For the ordinary retail shareholder, EPS is a great measure to check your hypothetical "share" of the company's profit.

That might leave you wondering what analysts forecast in terms of future profitability. Lucky, you can click here to see an interactive graph depicting future profitability based on their estimates.

The Impact Of Unusual Items On Profit

On top of the dilution, we should also consider the US$77m impact of unusual items in the last year, which suppressed profit. While deductions due to unusual items are disappointing in the first instance, there is a silver lining.

When we analyzed most listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Tilray took a rather significant hit from unusual items through 2021. All else being equal, this would likely have the effect of making the statutory profit look worse than its underlying earnings power.

Our Take On Tilray's Profit Performance

To sum it all up, Tilray took a hit from unusual items, which pushed its profit down; without that, it would have made more money. Even so, the company has been careful in its approach to the latest earnings presentation, avoiding the painful points.

Unfortunately, the dilution means that shareholders now own a smaller proportion of the company (assuming they maintained the same number of shares). That will weigh on earnings per share, even if it is not reflected in net income.

Based on these factors, it's hard to tell if Tilray's profits are a reasonable reflection of its underlying profitability. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Every company has risks, and we've spotted 3 warning signs for Tilray you should know about.

In this article, we've looked at a number of factors that can impair the utility of profit numbers as a guide to a business. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity to indicate favorable business economics, while others like to "follow the money" and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity or this list of stocks that insiders are buying.

Valuation is complex, but we're here to simplify it.

Discover if Tilray Brands might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Simply Wall St analyst Stjepan Kalinic and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

MI
mitchell_lawler
mitchell_lawler

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it.

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it. cover
179
ZO
zoe_vi5fn

Any moat with an opt-out clause for your competitors is just a fence around your own garden.

CO
connor_iwn1g

Worth looking at what previous legal action actually did to Meta rather than reaching for tobacco. The FTC's record five billion dollar privacy fine in 2019 was met with the stock rising, because it came in below fears and removed an open question. GDPR was designed to constrain large platforms and increased their share of the European ad market, because compliance cost fell hardest on small intermediaries. The FTC's antitrust case, the one that could genuinely have broken the company up, was decided in Meta's favour last November. The only thing that ever meaningfully hurt the business was Apple changing a tracking default, and Meta out-spent that too, while the ad-tech firms that could not afford to rebuild disappeared. The pattern is not that Meta survives regulation. It is that regulation keeps costing its smaller competitors more.

Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
10
ST
Stjepan Kalinic

Stjepan Kalinic

Stjepan is a writer and an analyst covering equity markets. As a former multi-asset analyst, he prefers to look beyond the surface and uncover ideas that might not be on retail investors' radar. You can find his research all over the internet, including Simply Wall St News, Yahoo Finance, Benzinga, Vincent, and Barron's.

About NasdaqGS:TLRY

Tilray Brands

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Excellent balance sheet and fair value.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.575.5% undervalued
31 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5861.4% undervalued
62 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.1% undervalued
65 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11632.1% undervalued
13 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

RO
RockeTeller
KUYA logo
RockeTeller on Kuya Silver ·

Kuya Silver, The High-Octane Rocket With 15,372 g/t Silver + $12 AISC

Fair Value:CA$10.8493.3% undervalued
10 users have followed this narrative
1 users have commented on this narrative
1 users have liked this narrative
RO
Robbo
ULVR logo
Robbo on Unilever ·

Unilever (LSE:ULVR), changes in the wind.

Fair Value:UK£42.2813.0% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TR
tripledub
DSK logo
tripledub on Dusk Group ·

Buying a Dollar for Fifty Cents: The Case for Dusk Group

Fair Value:AU$0.790.6% undervalued
24 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
363 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9122.3% overvalued
212 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.1% undervalued
125 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative

Trending Discussion